Completed PHASE2 INTERVENTIONAL 3-arm NCT00079781

RNS® System Feasibility Study

RNS® System Feasibility Clinical Investigation

Sponsor: NeuroPace

Conditions Epilepsy

Interventions RNS® System implantation RNS® System responsive stimulation

Updated 6 times since 2017 Last updated: Dec 23, 2013 Started: Jan 31, 2004 Primary completion: May 31, 2006 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00079781, this PHASE2 trial focuses on Epilepsy and remains completed. Sponsored by NeuroPace, it has been updated 6 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NeuroPace

Data source: NeuroPace

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augusta, United States , Baltimore, United States , Chicago, United States , Detroit, United States , Jacksonville, United States , New Haven, United States , New Orleans, United States , New York, United States , Phoenix, United States , Rochester, United States and 1 more location